| Sep 10 |
AstraZeneca Faces Setback From Lung Cancer Drug's Disappointing Trial Results
|
| Sep 10 |
Relay Stock Soars on Upbeat Data From Breast Cancer Study
|
| Sep 10 |
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
|
| Sep 10 |
AstraZeneca CEO Pascal Soriot Updates On Chinese Compliance Probe And Lung Cancer Drug Trial Results
|
| Sep 10 |
AstraZeneca's Investigational Cancer Drug Disappoints In Late-Stage Lung Cancer Trial
|
| Sep 10 |
New data add to doubts about AstraZeneca, Daiichi’s Enhertu successor
|
| Sep 10 |
5 Things to Know Before the Stock Market Opens
|
| Sep 10 |
AstraZeneca eyes up transition to eco-friendly inhaler propellant
|
| Sep 10 |
Stocks to Watch Tuesday: Apple, Oracle, Alibaba
|
| Sep 9 |
AstraZeneca reports disappointing Phase 3 data for lung cancer ADC
|
